Medindia

X

Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years

Friday, March 21, 2008 General News J E 4
Advertisement
WALTHAM, Mass., March 20 According to Millennium ResearchGroup's Global Markets for Atrial Fibrillation (AF) Treatment Devices 2008report, over 32,000 electrophysiology (EP) procedures were performed for thetreatment of AF in the US in 2007. AF EP procedure volumes will increase at acompound annual growth rate of over 25% from 2008 to 2012.

Growth in procedure volumes will be driven by the increasing physicianacceptance of EP ablation as a viable and effective treatment for AF. Over thenext several years, these procedures will be used more often over medicaltherapy than in the past. The introduction of new technology will alsosupport greater procedure volumes through 2012; these new devices will enablephysicians to increase the safety, efficiency, and efficacy of EP ablationcatheter procedures. By 2012, over 109,000 EP procedures will be performed totreat AF in the US.

"The patient pool that hasn't been treated in this market is huge andgrowing," says Andrew Wong, Analyst at Millennium Research Group. "Almost 3million people have atrial fibrillation in the US, but currently only about100,000 are being treated annually."

The Global Markets for Atrial Fibrillation Treatment Devices 2008 reportincludes coverage of the AF EP, cardiac rhythm management, and surgicalablation device markets. This report provides coverage of US, Europe, andJapan and all key industry competitors, including Biosense Webster, BostonScientific, Medtronic, and St. Jude Medical.

About Atrial Fibrillation

AF is a type of cardiac arrhythmia. In AF, the atria of the heart arestimulated by abnormal electrical impulses from the sinoatrial node andmalfunctioning atrial tissue, resulting in an irregular and disorganized heartbeat. AF can lead to heart failure and has been recognized as a major riskfactor for stroke. Increased age and unhealthy lifestyle choices are riskfactors in developing AF.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.

All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 akrohn@mrg.net

SOURCE Millennium Research Group
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Make Your Mammogram a Positive Experience: Author ...
S
PLC Systems Receives FDA Approval to Commence Pivo...